Publication almost a year old,... ResearchGate Jun
Post# of 148278
(Total Views: 609)
Posted On: 04/21/2023 8:24:24 PM
Publication almost a year old,... ResearchGate June 2022
"Fibroblast Growth Factor (FGF)-21 based therapies
"A Magic Bullet for Nonalcholic Fatty Liver Disease" (NAFLD)?
Expert Opin.Drugs 2020, 29. 197-204 (crossRef) [Pub Med].
Under References; #21
M.Ritchie, I.A. Hanouned, M. NOUREDDIN, T. Rolph, N. Alkhouri...
DECLARATION OF INTEREST
Dr. Mazen Noureddin receives research funding from BMS (the maker of pegbelfermin)....None of the authors have financial involvement with the subject matter or materials discussed in the manuscript.
Leronlimab is not mentioned...
how long has Dr. Noureddin been on our SAB?
"Fibroblast Growth Factor (FGF)-21 based therapies
"A Magic Bullet for Nonalcholic Fatty Liver Disease" (NAFLD)?
Expert Opin.Drugs 2020, 29. 197-204 (crossRef) [Pub Med].
Under References; #21
M.Ritchie, I.A. Hanouned, M. NOUREDDIN, T. Rolph, N. Alkhouri...
DECLARATION OF INTEREST
Dr. Mazen Noureddin receives research funding from BMS (the maker of pegbelfermin)....None of the authors have financial involvement with the subject matter or materials discussed in the manuscript.
Leronlimab is not mentioned...
how long has Dr. Noureddin been on our SAB?
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼